spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Automated Dried Spot Sampling and Analysis System Redefines Workflow

Thermo Fisher Scientific




SAN JOSE, Calif., – (August 3, 2022) – Thermo Fisher Scientific Inc., the world leader in serving science, enables clinical research, toxicology and anti-doping laboratories performing dried spot sampling and analysis to utilize a new automated sample prep and ultra-high-performance liquid chromatography (UHPLC) system to improve efficiency, robustness, sensitivity and sample traceability.



The new Thermo Scientific Transcend DSX-1 integrated sample prep and UHPLC system eliminates disc punching typically associated with dried matrix (spot) cards, and optimizes sample extraction and recovery of multiple matrices (e.g., blood, urine, serum and saliva). The new system enables laboratories performing routine analysis of drugs and other compounds to achieve substantial savings on time, labor and reagent costs compared to manual workflows. Proprietary flow-through desorption with heated capillary eliminates the need for manual, time-consuming extraction protocols and the automatic addition of an internal standard prior to the extraction minimizes matrix interference. Robustness and sensitivity are enhanced through online proprietary sample cleanup and enrichment via Thermo Scientific TurboFlow technology, producing confident results.

“Toxicology laboratories play a crucial role in detecting drug use and misuse in an ongoing struggle to safeguard society against increasing numbers of substances at ever decreasing concentrations. Dried spot analysis has emerged as a key technology in this area, requiring only a small amount of sample and, therefore, minimizing the user impact,” said Brad Hart, senior director, analytical vertical and life science mass spectrometry marketing, Thermo Fisher Scientific. “With the conventional workflow being held back by time-consuming manual procedures, we designed the Transcend DSX-1 system to ensure laboratories are able to effectively increase throughput to meet demand, while still ensuring the integrity and quality of results that are expected.”

Professor Mario Thevis, director for the Center for Preventative Doping Research, German Sport University, Cologne said, “Dried blood spot (DBS) tests have the potential to contribute substantially to an improved anti-doping testing program, today and in the future, supporting the clean athlete as well as the overall doping control analytical strategy. DBS analysis is the latest tool approved by the World Anti-Doping Agency (WADA) and was introduced at this year’s Winter Olympic Games in Beijing, China. In order to accommodate the specific needs associated with DBS analyses, and the considerable number of target analytes, robust, sensitive, programmable and especially automated DBS analytical options will offer critical advantages to anti-doping laboratories.”

The Transcend DSX-1 system is controlled by Thermo Scientific Aria MX software, which streamlines dried spot analysis by fully integrating all aspects of the workflow, such as:
  • Sample card handling
  • LC pump operation and valve switching
  • On-line sample clean-up
  • Liquid chromatography-tandem mass spectrometry methods

Furthermore, the Intelligent Vision Camera ensures data integrity and enables retrospective monitoring by capturing sample traceability, chain of custody and accurate spot recognition.

To find out more about the Transcend DSX-1 integrated sample prep and UHPLC system, please visit www.thermofisher.com/TranscendDSX.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

All rights reserved: Flow-through desorption (FTD).
phone 800-556-2323
web corporate.thermofisher.com/en/home.html
email 168 Third Avenue Waltham, MA 02451
 
Print this page
Send to a friend
   
spacer
News and Press Releases

UBC APPOINTS BEKKI BROWN PRESIDENT & CHIEF EXECUTIVE OFFICER

Effective January 1, 2023, Bekki Brown will assume the role of President & Chief Executive Officer of UBC
More info >>


White Papers

Clinical Trials in Russia Orange Paper: Summary of Year 2013

Synergy Research Group

Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia: 1. Fast patient enrollment due to the centralized medical infrastructure. 2. Nearly 100% patient retention 3. GCP trained and certified Investigative Sites generating high quality data 4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement